Cyclodextrin-Assisted Extraction and Encapsulation of Parthenolide- and Polyphenol-Rich Feverfew (Tanacetum parthenium L.) for Enhanced Bioactivity
Pharmaceuticals · 2026-07-27 · 19 (8) · 1176
DOI: 10.3390/ph19081176 ↗At a glance
Journal article in Pharmaceuticals, published online on 2026-07-27. Written by Nada Ćujić Nikolić and 8 co-authors. Institution: Institute for Medicinal Plants Research ''Dr. Josif Pančić'', 11000 Belgrade, Serbia. Cited 3 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science Fund of the Republic of Serbia.
Abstract (original language)
Background/Objectives: The extraction and encapsulation of Tanacetum parthenium L. (feverfew) represent highly relevant approaches for maximizing the recovery and protection of its bioactive phytocomplexes, particularly the main active compound, parthenolide (PAR). The present study aimed to develop and optimize a cyclodextrin-based extraction and encapsulation method for T. parthenium to improve the chemical and physicochemical properties and biological activity of bioactive-rich phytocomplexes.
Methods
The extraction process was optimized by comparing conventional maceration (ME) and ultrasound-assisted extraction (UE), using different ethanol–water mixtures as extractants, with and without hydroxypropyl-β-cyclodextrin (CD) as an extraction enhancer. The highest PAR yield (approximately 6.3 mg/g dried biomass), combined with enhanced total polyphenol and flavonoid contents, was achieved using 50% (v/v) ethanol with 0.5% CD under UE. The optimized extract was spray-dried to produce powder formulations, with or without carrier material, which have been characterized for their technological, chemical, physicochemical, structural, and biological properties.
Results
The inclusion of CD significantly improved process yield (approximately 65% compared to 47% for the non-encapsulated extract) and reduced residual moisture content, indicating enhanced drying efficiency and improved powder stability. Furthermore, the encapsulated formulation demonstrated preserved antioxidant and anti-inflammatory activity in cell-based assays.
Conclusions
The developed CD-based encapsulation method represents a promising strategy for stabilizing feverfew bioactives and enhancing their potential applicability in pharmaceutical and dermo-cosmetic formulations.
Subjects
Author keywords
Authors and institutions
- Institute for Medicinal Plants Research ''Dr. Josif Pančić'', 11000 Belgrade, Serbia.
- Vinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
- Institute for the Application of Nuclear Energy INEP, University of Belgrade, 11080 Belgrade, Serbia.
- Chemical Engineering Department, Loughborough University, Loughborough LE11 3TU, UK.
ORCID profiles: Nada Ćujić Nikolić, Dajana Lazarević, Aleksandra Jovanović, Jelena Jovanović, Katarina Šavikin, Gorana Ilić, Goran Vladisavljević, Tatjana Trtić-Petrović
Funding
- Science Fund of the Republic of Serbia
Cite
APA
Ćujić Nikolić, N., Lazarević, D., Jovanović, A., Jovanović, J., Šavikin, K., Nizar, N., Ilić, G., Vladisavljević, G., & Trtić-Petrović, T. (2026). Cyclodextrin-Assisted Extraction and Encapsulation of Parthenolide- and Polyphenol-Rich Feverfew (Tanacetum parthenium L.) for Enhanced Bioactivity. Pharmaceuticals, 19(8), 1176. https://doi.org/10.3390/ph19081176
Vancouver
Ćujić Nikolić N, Lazarević D, Jovanović A, Jovanović J, Šavikin K, Nizar N, et al. Cyclodextrin-Assisted Extraction and Encapsulation of Parthenolide- and Polyphenol-Rich Feverfew (Tanacetum parthenium L.) for Enhanced Bioactivity. Pharmaceuticals. 2026;19(8):1176. doi:10.3390/ph19081176
BibTeX
@article{ujiNikoli2026,
author = {Ćujić Nikolić, Nada and Lazarević, Dajana and Jovanović, Aleksandra and Jovanović, Jelena and Šavikin, Katarina and Nizar, Nibina and Ilić, Gorana and Vladisavljević, Goran and Trtić-Petrović, Tatjana},
title = {Cyclodextrin-Assisted Extraction and Encapsulation of Parthenolide- and Polyphenol-Rich Feverfew (Tanacetum parthenium L.) for Enhanced Bioactivity},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1176},
doi = {10.3390/ph19081176}
}
EUVIMED